Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound

Journal of Ultrasound in Medicine

Volumn 28, Issue 7, 2009, Pages 871-880

  Mei, Jie ^a   Cheng, Yuan ^a   Song, Yu ^a   Yang, Yanqing ^a   Wang, Feng ^a   Liu, Yingjiang ^a   Wang, Zhibiao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Focused ultrasound; Magnetic resonance imaging; Methotrexate; Targeted drug delivery

Indexed keywords

BLOOD; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETISM; RESONANCE; TISSUE; ULTRASONICS;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; CONTRAST-ENHANCED; FOCUSED ULTRASOUND; INTERNAL CAROTID ARTERY; METHOTREXATE; METHOTREXATE (MTX); TREATMENT METHODS;

TARGETED DRUG DELIVERY;

EVANS BLUE; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNAL CAROTID ARTERY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; ULTRASOUND;

EID: 67649757597     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2009.28.7.871     Document Type: Article

References (21)

1. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci 1999; 22:11-28. (Pubitemid 29144879)
2. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005; 2:3-14. (Pubitemid 40128022)
3. Pardridge WM. Drug and gene delivery to the brain: the vascular route. Neuron 2002; 36:555-558. (Pubitemid 35346750)
4. Pardridge WM. Drug and gene targeting to the brain with molecular Trojan horses. Nat Rev Drug Discov 2002; 1:131-139. (Pubitemid 41646520)
5. Pardridge WM. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain. Curr Opin Drug Discov Devel 2003; 6:683-691. (Pubitemid 37287937)
6. Doolittle ND, Miner ME, Hall WA, et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 2000; 88:637-647. (Pubitemid 30056941)
7. Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998; 42:1083-1099. (Pubitemid 28196521)
8. Guerin C, Olivi A, Weingart JD, Lawson HC, Brem H. Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs 2004; 22:27-37. (Pubitemid 38196980)
9. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 2005; 24:12-20. (Pubitemid 39611021)
10. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001; 220:640-646. (Pubitemid 32799969)
11. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive opening of BBB by focused ultrasound. Acta Neurochir Suppl 2003; 86:555-558.
12. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 2006; 340:1085-1090. (Pubitemid 43083389)
13. Levin VA, Kabra PM, Freeman-Dove MA. Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey. J Neurosurg 1978; 48:587-593. (Pubitemid 8311446)
14. Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 2003; 6:252-273. (Pubitemid 37207232)
15. Chabner BA, Young RC. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. J Clin Invest 1973; 52:1804-1811.
16. Beissner K. Measurement techniques. In: Ziskin MC, Lewin PA (eds). Ultrasonic Exposimetry. 1st ed. Boca Raton, FL; CRC Press; 1993:127-142.
17. McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 2005; 31:1527-1537. (Pubitemid 41606266)
18. Choi JJ, Pernot M, Small SA, Konofagou EE. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med Biol 2007; 33:95-104. (Pubitemid 44959316)
19. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007; 121: 901-907.
20. Hynynen K, McDannold N, Vykhodtseva N, et al. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound burst: a method for molecular imaging and targeted drug delivery. J Neurosurg 2006; 105:445-454. (Pubitemid 44358757)
21. Hynynen K, Clement GT, McDannold N, et al. 500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn Reson Med 2004; 52:100-107. (Pubitemid 39295261)